VGT has hit a new high and is approaching its 52-week peak. Technology continues to lead the way, and the halo of AI hasn't faded at all. I, who missed the boat, am doing mental exercises every day.
XLV has surprisingly risen nearly 12% this year, with the healthcare sector quietly gaining strength. However, the sector is indeed slow to warm up—only those who hold on can enjoy the dividends.
XBI has been a bit weak recently, first surging and then being sold off by funds. Before you know it, it's trapped at high levels again. Biotech is truly a rollercoaster every day.
With these ETFs in hand, I talk about being zen, but my actions speak louder than words.
The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
